Related references
Note: Only part of the references are listed.Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
Jasmin Jo et al.
NEURO-ONCOLOGY (2022)
Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
Fleur H. J. Kaptein et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism in patients with IDH1 wild-type glioblastoma
Yong Huang et al.
SUPPORTIVE CARE IN CANCER (2022)
Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis
Soon Khai Low et al.
THROMBOSIS RESEARCH (2022)
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors
Andrew Dunbar et al.
BLOOD (2021)
Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype
Maria Diaz et al.
NEUROLOGY (2021)
Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles
Nadim Tawil et al.
BLOOD ADVANCES (2021)
Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma
Yoshinari Osada et al.
BRAIN TUMOR PATHOLOGY (2021)
Optimal timing of post-operative enoxaparin after neurosurgery: A single institution experience
Robert G. Briggs et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
IDH mutation status and the development of venous thromboembolism in astrocytoma patients
Jacob J. Mandel et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis
Araci M. R. Rondon et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Podoplanin Expression and IDH-Wildtype Status Predict Venous Thromboembolism in Patients with High-Grade Gliomas in the Early Postoperative Period
Jun Watanabe et al.
WORLD NEUROSURGERY (2019)
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers
Dusten Unruh et al.
SCIENTIFIC REPORTS (2019)
Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin
Katsue Suzuki-Inoue
BLOOD (2019)
Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas
Dusten Unruh et al.
CLINICAL CANCER RESEARCH (2019)
Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism
P. Mir Seyed Nazari et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Venous Thromboembolism Advances in Diagnosis and Treatment
Tobias Tritschler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Management of venous thromboembolism in patients with glioma
Mosaad Al Megren et al.
THROMBOSIS RESEARCH (2017)
Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin
Charlene Mantia et al.
BLOOD (2017)
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism
Julia Riedl et al.
BLOOD (2017)
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors
Marina N. Nikiforova et al.
NEURO-ONCOLOGY (2016)
Mutant IDH1 and thrombosis in gliomas
Dusten Unruh et al.
ACTA NEUROPATHOLOGICA (2016)
A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation
J. I. Zwicker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays
Yohei Hisada et al.
THROMBOSIS RESEARCH (2016)
Venous thrombosis in patients with high-grade glioma
Sophie Taillibert et al.
CURRENT OPINION IN ONCOLOGY (2015)
Venous thromboembolism (VTE) and glioblastoma
Shlomit Yust-Katz et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period
Timothy R. Smith et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH
J. Geddings et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas
Johannes Thaler et al.
NEURO-ONCOLOGY (2014)
Thrombosis in Brain Tumors
Jasmin T. Jo et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2014)
Risk factors for inpatient venous thromboembolism despite thromboprophylaxis
Tzu-Fei Wang et al.
THROMBOSIS RESEARCH (2014)
What do we know about IDH1/2 mutations so far, and how do we use it?
Craig Horbinski
ACTA NEUROPATHOLOGICA (2013)
Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients
Julia E. Geddings et al.
BLOOD (2013)
Epidemiology of cancer-associated venous thrombosis
Jasmijn F. Timp et al.
BLOOD (2013)
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
Masato Sasaki et al.
GENES & DEVELOPMENT (2012)
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
J. Thaler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Thromboembolic disease in patients with high-grade glioma
James R. Perry
NEURO-ONCOLOGY (2012)
Patterns in neurosurgical adverse events: intracranial neoplasm surgery
Judith M. Wong et al.
NEUROSURGICAL FOCUS (2012)
Oncogenic regulation of tissue factor and thrombosis in cancer
Monika Anand et al.
THROMBOSIS RESEARCH (2012)
Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles
Maria Teresa Sartori et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Venous thromboembolism in malignant gliomas
E. O. Jenkins et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism
David A. Manly et al.
THROMBOSIS RESEARCH (2010)
Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy
Jeffrey I. Zwicker et al.
CLINICAL CANCER RESEARCH (2009)
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer
Alok A. Khorana et al.
CLINICAL CANCER RESEARCH (2007)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Survival model predictive accuracy and ROC curves
PJ Heagerty et al.
BIOMETRICS (2005)
Share Paper
